Aptahem AB (STU:94V) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:94V Aptahem AB STU:94V
30 GF Score
Price €0.07
! 2 Warning Signs
View Full Analysis

What is Aptahem AB FFO?

FFO (Funds from operations) only applies to REITs.

STU:94V
30GF Score
Aptahem AB STU:94V
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aptahem AB Business Description

Other Exchanges APTA:Sweden
Address Norra Vallgatan 58, Malmo, SWE, 211 22
Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.
30GF Score

Get the complete analysis for STU:94V

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.07
Price